| Code | 5547D | ||||||||||
| MA number | 21/0197/20-S | ||||||||||
| Product Form: | tbl ent 100x300 mg (obal PE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | plastic container | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 07.07.1992 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Orfiril tbl ent_09.2020.docx
|
| PIL: |
PIL_Orfiril tbl ent_09.2020.docx
|
| Safety feature | Yes |
| Data update: | 22.09.2020 |
